[1]
Fontan, F.; Mounicot, F.B.; Baudet, E.; Simonneau, J.; Gordo, J.; Gouffrant, J.M. “Correction” of tricuspid atresia. 2 cases “corrected” using a new surgical technic. Ann. Chir. Thorac. Cardiovasc., 1971, 10, 39-47.
[2]
de Leval, M.R. The Fontan circulation: A challenge to William Harvey? Nat. Clin. Pract. Cardiovasc. Med., 2005, 2, 202-208.
[3]
Cheng, A.L.; Takao, C.M.; Wenby, R.B.; Meiselman, H.J.; Wood, J.C.; Detterich, J.A. Elevated low-shear blood viscosity is associated with decreased pulmonary blood flow in children with univentricular heart defects. Pediatr. Cardiol., 2016, 37(4), 789-801.
[4]
Jolley, M.; Colan, S.D.; Rhodes, J.; DiNardo, J. Fontan physiology revisited. Anesth. Analg., 2015, 121, 172-182.
[5]
Ohuchi, H. Where is the “optimal” Fontan hemodynamics. Korean Circ. J., 2017, 47, 842-857.
[6]
Gersony, W.M. Fontan operation after 3 decades: What we have learned. Circulation, 2008, 117, 13-15.
[7]
Kukreja, M.; Bryant, A.S.; Cleveland, D.C.; Dabal, R.; Hingorani, N.; Kirklin, J.K. Health-Related quality of life in adult survivors after the fontan operation. Semin. Thorac. Cardiovasc. Surg., 2015, 27, 299-306.
[8]
Uzark, K.; Zak, V.; Shrader, P.; McCrindle, B.W.; Radojewski, E.; Varni, J.W.; Daniels, K.; Handisides, J.; Hill, K.D.; Lambert, L.M.; Margossian, R.; Pemberton, V.L.; Lai, W.W.; Atz, A.M. Assessment of quality of life in young patients with single ventricle after the fontan operation. J. Pediatr., 2016, 170, 166-172.
[9]
D’Udekem, Y.; Iyengar, A.J.; Galati, J.C.; Forsdick, V.; Weintraub, R.G.; Wheaton, G.R.; Bullock, A.; Justo, R.N.; Grigg, L.E.; Sholler, G.F.; Hope, F.; Radford, D.J.; Gentles, T.L.; Celermajer, D.S.; Winlaw, D.S. Redefining expectations of long-term survival after the Fontan procedure: Twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation, 2014, 130, S32-S38.
[10]
Gewillig, M.; Goldberg, D.J. Failure of the fontan circulation. Heart Fail. Clin., 2014, 10, 105-116.
[12]
Marino, B.S.; Goldberg, D.J.; Dorfman, A.L.; Kind, E.; Kalkwarf, H.; Zemel, B.S.; Smith, M.; Pratt, J.; Fogel, M.A.; Shilingford, A.J.; Deal, B.J.; John, A.S.; Goldberg, C.S.; Hoffmann, T.M.; Jacobs, M.L.; Lisec, A.; Finan, S.; Kochilas, L.K.; Pawlowski, T.W.; Campbell, K.; Joiner, C.; Goldstein, S.L.; Stephens, R.; Chin, A.J. Abormalities in serum biomarkers correlate with lower cardiac index in the Fontan population. Cardiol. Young, 2017, 27(1), 59-68.
[13]
Neubauer, S. The failing heart - an engine out of fuel. N. Engl. J. Med., 2007, 356(11), 1140-1151.
[14]
Alsaied, T.; Bokma, J.P.; Engel, M.E.; Kuijpers, J.M.; Hanke, S.P.; Zuhlke, L.; Zhang, B.; Veldtman, G.R. Predicting long-term mortality after Fontan procedures: A risk score based on 6707 patients from 28 studies. Congenit. Heart Dis., 2017, 12(4), 393-398.
[15]
Talwar, S.; Singh, S.; Sreenivas, V.; Kapoor, K.S.; Gupta, S.K.; Ramakrishnan, S.; Kothari, S.S.; Saxena, A.; Juneja, R.; Choudhary, S.K.; Airan, B. Outcomes of patients undergoing primary Fontan operation beyond first decade of life. World J. Pediatr. Congenit. Heart Surg., 2017, 8(4), 487-494.
[16]
Gelatt, M.; Hamilton, R.M.; McCrindle, B.W.; Gow, R.M.; Williams, W.G.; Trusler, G.A.; Freedom, R.M. Risk factors for atrial tachyarrhythmias after the Fontan operation. J. Am. Coll. Cardiol., 1994, 24, 1735-1741.
[17]
Stephenson, E.A.; Lu, M.; Berul, C.L.; Etheridge, S.P.; Idriss, S.F.; Margossian, R.; Reed, R.H.; Prakash, A.; Sleeper, L.A.; Vetter, V.L.; Blaufox, A.D. Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J. Am. Coll. Cardiol., 2010, 56, 890-896.
[18]
Egbe, A.C.; Connolly, H.M.; McLeod, C.J.; Ammash, N.M.; Niaz, T.; Yogeswaran, V.; Poterucha, J.T.; Qureshi, M.Y.; Driscoll, D.J. Thrombotic and embolic complications associated with atrial arrhythmia after Fontan operation. J. Am. Coll. Cardiol., 2016, 68, 1312-1319.
[19]
Liang, F.; Senzaki, H.; Kurishima, C.; Sughimoto, K.; Inuzuka, R.; Liu, H. Hemodynamic performance of the Fontan circulation compared with a normal biventricular circulation: A computational model study. Am. J. Physiol. Heart Circ. Physiol., 2014, 307, H1056-H1072.
[20]
Anderson, P.A.; Sleeper, L.A.; Mahony, L.; Uzark, K.; Shrader, P.; Gallagher, D.; Paridon, S.M.; Williams, R.V.; Breitbart, R.E.; Colan, S.D.; Kaltman, J.R.; Margossian, R.; Pasquali, S.K.; Allen, K.; Lai, W.W.; Korsin, R.; Marino, B.S.; Mirarchi, N.; McCrindle, B.W. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J. Am. Coll. Cardiol., 2008, 52, 85-98.
[21]
Michel, M.; Logoteta, J.; Entenmann, A.; Hansen, J.H.; Voges, I.; Kramer, H.H.; Petko, C. Decline of systolic and diastolic 2D Strain Rate during follow-up of HLHS patients after Fontan palliation. Pediatr. Cardiol., 2016, 37, 1250-1257.
[22]
Nakamura, Y.; Yagihara, T.; Kagisaki, K.; Hagino, I.; Kobayashi, J. Ventricular performance in long-term survivors after Fontan operation. Ann. Thorac. Surg., 2011, 91, 172-180.
[23]
Cohen, M.S.; Marino, B.S.; McElhinney, D.B.; Robbers-Visser, D.; van der Woerd, W.; Gaynor, J.W.; Spray, T.L.; Wernovsky, G. Neo-aortic root dilation and valve regurgitation up to 21 years after staged reconstruction for hypoplastic left heart syndrome. J. Am. Coll. Cardiol., 2003, 42, 533-540.
[24]
Kaulitz, R.; Ziemer, G.; Paul, T.; Peuster, M.; Bertram, H.; Hausdorf, G. Fontan-type procedures: redidual lesions and late interventions. Ann. Thorac. Surg., 2002, 74(3), 778-785.
[25]
Schumacher, K.R.; Singh, T.P.; Kuebler, J.; Aprile, K.; O’Brien, M.; Blume, E.D. Risk factors and outcome of Fontan-associated plastic bronchitis: A case-control study. J. Am. Heart Assoc., 2014, 3e000865
[26]
Ridderbos, F.J.; Wolff, D.; Timmer, A.; Van Melle, J.P.; Ebels, T.; Dickinson, M.G.; Timens, W.; Berger, R.M. Adverse pulmonary vascular remodeling in the Fontan circulation. J. Heart Lung Transplant., 2015, 34, 404-413.
[27]
Larsson, E.S.; Eriksson, B.O.; Sixt, R. Decreased lung function and exercise capacity in Fontan patients: A long-term follow-up. Scand. Cardiovasc. J., 2003, 37, 58-63.
[28]
Khiabani, R.H.; Whitehead, K.K.; Han, D.; Restrepo, M.; Tang, E.; Bethel, J.; Paridon, S.M.; Fogel, M.A.; Yoganathan, A.P. Exercise capacity in single-ventricle patients after Fontan correlates with haemodynamic energy loss in TCPC. Heart, 2015, 101, 139-143.
[29]
Ohuchi, H.; Negishi, J.; Noritake, K.; Hayama, Y.; Sakaguchi, H.; Miyazaki, A.; Kagisaki, K.; Yamada, O. Prognostic value of exercise variables in 335 patients after the fontan operation: A 23-year single-center experience of cardiopulmonary exercise testing. Congenit. Heart Dis., 2015, 10, 105-116.
[30]
Brassard, P.; Bédard, E.; Jobin, J.; Rodès-Cabau, J.; Poirier, P. Exercise capacity and impact of exercise training in patients after a Fontan procedure: A review. Can. J. Cardiol., 2006, 22(6), 489-495.
[31]
Cordina, R.; O’Meagher, S.; Gould, H.; Rae, C.; Kemp, G.; Pasco, J.A.; Celermajer, D.S.; Singh, N. Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart, 2013, 99, 1530-1534.
[32]
Jin, S.M.; Noh, C.I.; Bae, E.J.; Choi, J.Y.; Yun, Y.S. Impaired vascular function in patients with Fontan circulation. Int. J. Cardiol., 2007, 120, 221-226.
[33]
Tomkiewicz-Pajak, L.; Dziedzic-Oleksy, H.; Pajak, J.; Olszowska, M.; Kolcz, J.; Komar, M.; Podolec, P. Arterial stiffness in adult patients after Fontan procedure. Cardiovasc. Ultrasound, 2014, 12, 15.
[34]
Ohuchi, H.; Yasuda, K.; Miyazaki, A.; Kitano, M.; Sakaguchi, H.; Yazaki, S.; Tsuda, E.; Yamada, O. Hemodynamic Characteristics before and after the onset of protein losing enteropathy in patients after the Fontan Operation. Eur. J. Cardiothorac. Surg., 2013, 43, e49-E57.
[35]
Rychik, J.; Gui-Yang, S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am. J. Cardiol., 2002, 90, 672-674.
[36]
Rychik, J.; Goldberg, D.; Rand, E.; Semeao, E.; Russo, P.; Dori, Y.; Dodds, K. End-organ consequences of the Fontan operation: Liver fibrosis, protein-losing enteropathy and plastic bronchitis. Cardiol. Young, 2013, 23, 831-840.
[37]
Camposilvan, S.; Milanesi, O.; Stellin, G.; Pettenazzo, A.; Zancan, L.; D’Antiga, L. Liver and cardiac function in the long term after Fontan operation. Ann. Thorac. Surg., 2008, 86, 177-182.
[38]
Mattes, M.; Connor, J.; Kelly, S.S.; Schwartz, M.C. Lymphopenia in patients with single-ventricle heart disease after the fontan operation. Congenit. Heart Dis., 2015, 11(3), 270-275.
[39]
Ohuchi, H.; Yasuda, K.; Miyazaki, A.; Iwasa, T.; Sakaguchi, H.; Shin, O.; Mizuno, M.; Negishi, J.; Noritake, K.; Yamada, O. Comparison of prognostic variables in children and adults with Fontan circulation. Int. J. Cardiol., 2014, 173, 277-283.
[40]
Ostrow, A.M.; Freeze, H.; Rychik, J. Protein-losing enteropathy after fontan operation: Investigations into possible pathophysiologic mechanisms. Ann. Thorac. Surg., 2006, 82, 695-700.
[41]
Patel, J.K.; Loomes, K.M.; Goldberg, D.J.; Mercer-Rosa, L.; Dodds, K.; Rychik, J. Early impact of fontan operation on enteric protein loss. Ann. Thorac. Surg., 2016, 101, 1025-1030.
[42]
Kaulitz, R.; Haber, P.; Sturm, E.; Schafer, J.; Hofbeck, M. Serial evaluation of hepatic function profile after Fontan operation. Herz, 2014, 39, 98-104.
[43]
Kaulitz, R.; Luhmer, I.; Bergmann, F.; Rodeck, B.; Hausdorf, G. Sequelae after modified Fontan operation: Postoperative haemodynamic data and organ function. Heart, 1997, 78, 154-159.
[44]
Yoo, B.W.; Choi, J.Y.; Eun, L.Y.; Park, H.K.; Park, Y.H.; Kim, S.U. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J. Thorac. Cardiovasc. Surg., 2014, 148, 1498-1505.
[45]
van Nieuwenhuizen, R.C.; Peters, M.; Lubbers, L.J.; Trip, M.D.; Tijssen, J.G.; Mulder, B.J. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart, 1999, 82, 40-46.
[46]
Friedrich-Rust, M.; Koch, C.; Rentzsch, A.; Sarrazin, C.; Schwarz, P.; Hermann, E.; Lindinger, A.; Sarrazin, U.; Poynard, T.; Schäfers, H.J.; Zeuzem, S.; Abdul-Kaliq, H. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J. Thorac. Cardiovasc. Surg., 2008, 135, 560-567.
[47]
Kutty, S.S.; Peng, Q.; Danford, D.A.; Fletcher, S.E.; Perry, D.; Talmon, G.A.; Scott, C.; Kugler, J.D.; Duncan, K.F.; Quiros-Tejeira, R.E.; Kutty, S. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: A vascular Doppler and elastography study. Hepatology, 2014, 59, 251-260.
[48]
Lindsay, I.; Johnson, J.; Everitt, M.D.; Hoffman, J.; Yetman, A.T. Impact of liver disease after the fontan operation. Am. J. Cardiol., 2015, 115, 249-252.
[49]
Mori, M.; Aguirre, A.J.; Elder, R.W.; Kashkouli, A.; Farris, A.B.; Ford, R.M.; Book, W.M. Beyond a broken heart: Circulatory dysfunction in the failing. Fontan. Pediatr. Cardiol., 2014, 35, 569-579.
[50]
Wu, F.M.; Jonas, M.M.; Opotowsky, A.R.; Harmon, A.; Raza, R.; Ukomadu, C.; Landzberg, M.J.; Singh, M.N.; Valente, A.M.; Egidy Assenza, G.; Perez-Atayde, A.R. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J. Heart Lung Transplant., 2015, 34(7), 883-891.
[51]
Hayashi, T.; Inuzuka, R.; Shindo, T.; Hirata, Y.; Shimizu, N.; Oka, A. Serum hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics. Pediatr. Cardiol., 2014, 35, 608-615.
[52]
Elder, R.W.; McCabe, N.M.; Hebson, C.; Veledar, E.; Romero, R.; Ford, R.M.; Mahle, W.T.; Kogon, B.E.; Sahu, A.; Jokhadar, M.; McConnell, M.E.; Book, W.M. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int. J. Cardiol., 2013, 168, 3764-3769.
[53]
Greenway, S.C.; Crossland, D.S.; Hudson, M.; Martin, S.R.; Myers, R.P.; Prieur, T.; Hasan, A.; Kirk, R. Fontan-associated liver disease: Implications for heart transplantation. J. Heart Lung Transplant., 2016, 35, 26-33.
[54]
Collins, N.; Piran, S.; Harrison, J.; Azevedo, E.; Oechslin, E.; Silversides, C.K. Prevalence and determinants of anemia in adults with complex congenital heart disease and ventricular dysfunction (subaortic right ventricle and single ventricle physiology). Am. J. Cardiol., 2008, 102, 625-628.
[55]
Anne, P.; Du, W.; Mattoo, T.K.; Zilberman, M.V. Nephropathy in patients after Fontan palliation. Int. J. Cardiol., 2009, 132, 244-247.
[56]
Esch, J.J.; Salvin, J.M.; Thiagarajan, R.R.; Del Nido, P.J.; Rajagopal, S.K. Acute kidney injury after Fontan completion: Risk factors and outcomes. J. Thorac. Cardiovasc. Surg., 2015, 150, 190-197.
[57]
Sharma, S.; Ruebner, R.L.; Furth, S.L.; Dodds, K.M.; Rychik, J.; Goldberg, D.J. Assessment of kidney function in survivors following Fontan palliation. Congenit. Heart Dis., 2016, 11(6), 630-636.
[58]
Opotowsky, A.R.; Baraona, F.R.; McCausland, F.R.; Loukas, B.; Landzberg, E.; Landzberg, M.J.; Sabbisetti, V.; Waikar, S.S. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation. Heart, 2017, 103(6), 434-442.
[59]
du Plessis, A.J.; Chang, A.C.; Wessel, D.L.; Lock, J.E.; Wernovsky, G.; Newburger, J.W.; Mayer, J.E. Jr. Cerebrovascular accidents following the Fontan operation. Pediatr. Neurol., 1995, 12, 230-236.
[60]
Saiki, H.; Kurishima, C.; Masutani, S.; Senzaki, H. Cerebral circulation in patients with Fontan circulation: Assessment by carotid arterial wave intensity and stiffness. Ann. Thorac. Surg., 2014, 97, 1394-1399.
[61]
Acampa, M.; Romano, D.G.; Lazzerini, P.E.; Leonini, S.; Guideri, F.; Casseri, T.; Bracco, S.; Martini, G. Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion. Curr. Neurovasc. Res., 2018, 15, 34-38.
[62]
Sarrechia, I.; Miatton, M.; De Wolf, D.; Francois, K.; Gewillig, M.; Meyns, B.; Vingerhoets, G. Neurocognitive development and behaviour in school-aged children after surgery for univentricular or biventricular congenital heart disease. Eur. J. Cardiothorac. Surg., 2016, 49(1), 167-174.
[63]
Goldberg, C.S.; Schwartz, E.M.; Brunberg, J.A.; Mosca, R.S.; Bove, E.L.; Schork, M.A.; Stetz, S.P.; Cheatham, J.P.; Kulik, T.J. Neurodevelopmental outcome of patients after the fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J. Pediatr., 2000, 137, 646-652.
[64]
Coon, P.D.; Rychik, J.; Novello, R.T.; Ro, P.S.; Gaynor, J.W.; Spray, T.L. Thrombus formation after the Fontan operation. Ann. Thorac. Surg., 2001, 71, 1990-1994.
[65]
Tomkiewicz-Pajak, L.; Hoffman, P.; Trojnarska, O.; Lipczynska, M.; Podolec, P.; Undas, A. Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J. Thorac. Cardiovasc. Surg., 2014, 147, 1284-1290.
[66]
Walker, H.A.; Gatzoulis, M.A. Prophylactic anticoagulation following the Fontan operation. Heart, 2005, 91, 854-856.
[67]
Balling, G. Fontan anticoagulation: A never-ending debate? J. Am. Coll. Cardiol., 2016, 68(12), 1320-1322.
[68]
Tomkiewicz-Pajak, L.; Plazak, W.; Kolcz, J.; Pajak, J.; Kopec, G.; Dluzniewska, N.; Olszowska, M.; Moryl-Bujakowska, A.; Podolec, P. Iron deficiency and hematological changes in adult patients after Fontan operation. J. Cardiol., 2014, 64, 384-389.
[69]
Magdo, H.S.; Stillwell, T.L.; Greenhawt, M.J.; Stringer, K.A.; Yu, S.; Fifer, C.G.; Russell, M.W.; Schumacher, K.R. Immune Abnormalities in fontan protein-losing enteropathy: A case-control study. J. Pediatr., 2015, 167, 331-337.
[70]
Lenz, D.; Hambsch, J.; Schneider, P.; Tarnok, A. Protein-losing enteropathy after fontan surgery: Is assessment of risk patients with immunological data possible? Cytometry B Clin. Cytom., 2003, 53, 34-39.
[71]
Lechner, E.; Gitter, R.; Mair, R.; Pinter, M.; Schreier-Lechner, E.; Vondrys, D.; Tulzer, G. Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatr. Cardiol., 2008, 29, 901-905.
[72]
D’Udekem, Y.; Cheung, M.M.H.; Setyapranata, S.; Iyengar, A.J.; Kelly, P.; Buckland, N.; Grigg, L.E.; Weintraub, R.G.; Vance, A.; Brizard, C.P.; Penny, D.J. How good is a good Fontan? Quality of life and exercise capacity of Fontan patients without late arrhythmia. Ann. Thorac. Surg., 2009, 88, 1961-1969.
[73]
Raedle-Hurst, T.M.; Koenigstein, K.; Gruenhage, F.; Raedle, J.; Herrmann, E.; Abdul-Khaliq, H. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts. Am. Heart J., 2010, 160, 1105-1112.
[74]
Ono, M.; Boethig, D.; Goerler, H.; Lange, M.; Westhoff-Bleck, M.; Breymann, T. Somatic development long after the Fontan operation: Factors influencing catch-up growth. J. Thorac. Cardiovasc. Surg., 2007, 134, 1199-1206.
[75]
Vogt, K.N.; Manlhiot, C.; Van Arsdell, G.; Russell, J.L.; Mital, S.; McCrindle, B.W. Somatic growth in children with single ventricle physiology impact of physiologic state. J. Am. Coll. Cardiol., 2007, 50, 1876-1883.
[76]
Holler, F.; Hannes, T.; Germund, I.; Emmel, M.; Hoyer-Kohn, H.; Khalil, M.; Sreeram, N.; Udink Ten Cate, F.E. Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients. Cardiol. Young, 2016, 26(5), 876-884.
[77]
Avitabile, C.M.; Leonard, M.B.; Zemel, B.S.; Brodsky, J.L.; Lee, D.; Dodds, K.; Hayden-Rush, C.; Whitehead, K.K.; Goldmuntz, E.; Paridon, S.M.; Rachik, S.M.; Goldberg, D.J. Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation. Heart, 2014, 100, 1702-1707.
[78]
Ohuchi, H.; Takasugi, H.; Ohashi, H.; Yamada, O.; Watanabe, K.; Yagihara, T.; Echigo, S. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients. Circulation, 2004, 110, 2601-2608.
[79]
Ohuchi, H.; Negishi, J.; Ono, S.; Miyake, A.; Toyota, N.; Tamaki, W.; Miyazaki, A.; Yamada, O. Hyponatremia and its association with the neurohormonal activity and adverse clinical events in children and young adult patients after the Fontan operation. Congenit. Heart Dis., 2011, 6, 304-312.
[80]
Burchill, L.J.; Redington, A.N.; Silversides, C.K.; Ross, H.J.; Jimenez-Juan, L.; Mital, S.; Oechslin, E.N.; Dragulescu, A.; Slorach, C.; Mertens, L.; Wald, R.M. Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation. Int. J. Cardiol., 2015, 197, 209-215.
[81]
Ohuchi, H.; Negishi, J.; Miyake, A.; Sakaguchi, H.; Miyazaki, A.; Yamada, O. Long-term prognostic value of cardiac autonomic nervous activity in postoperative patients with congenital heart disease. Int. J. Cardiol., 2011, 151, 296-302.
[82]
Acampa, M.; Lazzerini, P.E.; Martini, G. Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers. Front. Neurol., 2018, 9, 469.
[83]
Ohuchi, H.; Negishi, J.; Hayama, Y.; Sasaki, O.; Taniguchi, Y.; Noritake, K.; Miyazaki, A.; Yamada, O. Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation. Int. J. Cardiol., 2015, 184, 623-630.
[84]
Ohuchi, H.; Miyamoto, Y.; Yamamoto, M.; Ishihara, H.; Takata, H.; Miyazaki, A.; Yamada, O.; Yagihara, T. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am. Heart J., 2009, 158, 30-39.
[85]
Ohuchi, H.; Yasuda, K.; Ono, S.; Hayama, Y.; Megishi, J.; Noritake, K.; Mizuno, M.; Iwasa, T.; Miyazaki, A.; Yamada, O. Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease. Int. J. Cardiol., 2014, 174, 306-312.
[86]
Whiteside, W.; Tan, M.; Ostlund, R.E. Jr., Yu, S.; Ma, L.; Rocchini, A. Altered cholesterol metabolism and hypocholesterolemia in patients with single ventricle following fontan palliation. J. Pediatr., 2016, 171, 73-77.
[87]
Whiteside, W.; Tan, M.; Yu, S.; Rocchini, A. Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation. J. Pediatr., 2013, 162, 1199-1204.
[88]
Zyblewski, S.C.; Argraves, W.S.; Graham, E.M.; Slate, E.H.; Atz, A.M.; Bradley, S.M.; McQuinn, T.C.; Wilkerson, B.A.; Wing, S.B.; Argraves, K.M. Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation. Pediatr. Cardiol., 2012, 33, 1154-1159.
[89]
Yancy, C.W.; Jessup, M.; Bozkurt, B.; Butler, J.; Casey, D.E. Jr, Colvin, M.M.; Drazner, M.H.; Filippatos, G.S.; Fonarow, G.C.; Givertz, M.M.; Hollenberg, S.M.; Lindenfeld, J.; Masoudi, F.A.; McBride, P.E.; Peterson, P.N.; Stevenson, L.W.; Westlake, C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation, 2017, 136, e137-e161.
[90]
Ventura-Clapier, R.; Garnier, A.; Veksler, V. Energy metabolism in heart failure. J. Physiol., 2004, 555, 1-13.
[91]
Chung, S.T.; Hong, B.; Patterson, L.; Petit, C.J.; Ham, J.N. High overweight and obesity in fontan patients: A 20-year history. Pediatr. Cardiol., 2016, 37, 192-200.
[92]
Shibayama, J.; Yuzyuk, T.N.; Cox, J.; Makaju, A.; Miller, M.; Lichter, J.; Li, H.; Leavy, J.D.; Franklin, S.; Zaitsev, A.V. Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: Integrated metabolomics and proteomics study. PLoS One, 2015, 10e0118974
[93]
Gehmlich, K.; Dodd, M.S.; Allwood, J.W.; Kelly, M.; Bellahcene, M.; Lad, H.V.; Stockenhuber, A.; Hooper, C.; Ashrafian, H.; Redwood, C.S.; Carrier, L.; Dunn, W.B. Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy. Mol. Biosyst., 2015, 11, 564-573.
[94]
Lai, L.; Leone, T.C.; Keller, M.P.; Martin, O.J.; Broman, A.T.; Nigro, J.; Kapoor, K.; Koves, T.R.; Stevens, R.; Ilkayeva, O.R.; Vega, R.B. ATtie, A.D.; Muoio, D.M.; Kelly, D.P. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: A multisystems approach. Circ Heart Fail, 2014, 7, 1022-1031.
[95]
Hill, B.G.; Schulze, P.C. Insights into metabolic remodeling of the hypertrophic and failing myocardium. Circ Heart Fail, 2014, 7, 874-876.
[96]
Aubert, G.; Martin, O.J.; Horton, J.L.; Lai, L.; Vega, R.B.; Leone, T.C.; Koves, T.; Gardell, S.J.; Krüger, M.; Hoppel, C.L.; Lewandowski, E.D.; Crawford, P.A.; Muoio, D.M.; Kelly, D.P. The failing heart relies on ketone bodies as a fuel. Circulation, 2006, 133, 698-705.
[97]
Bedi, K.C. Jr., Snyder, N.W.; Brandimarto, J.; Aziz, M.; Mesaros, C.; Worth, A.J.; Wang, L.L.; Javaheri, A.; Blair, I.A.; Margulies, K.B.; Rame, J.E. Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation, 2016, 133, 706-716.
[98]
Zordoky, B.N.; Sung, M.M.; Ezekowitz, J.; Mandal, R.; Han, B.; Bjorndahl, T.C.; Bouatra, S.; Anderson, T.; Oudit, G.Y.; Wishart, D.S.; Dyck, J.R. Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One, 2015, 10(5)e0124844
[99]
Goldberg, D.J.; Surrey, L.F.; Glatz, A.C.; Dodds, K.; O’Byrne, M.L.; Lin, H.C.; Fogel, M.; Rome, J.J.; Rand, E.B.; Russo, P.; Rychik, J. Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: A liver biopsy and hemodynamic study. J. Am. Heart Assoc., 2017, 6e004809
[100]
Mizuno, M.; Ohuchi, H.; Matsuyama, T.A.; Miyazaki, A.; Ishibashi-Ueda, H.; Yamada, O. Diverse multi-organ histopathologic changes in a failed Fontan patient. Pediatr. Int. , 2016, 58, 1061-1065.
[101]
Furukawa, T.; Akimoto, K.; Ohtsuki, M.; Sato, K.; Suzuki, M.; Takahashi, K.; Kishiro, M.; Shimizu, T.; Kawasaki, S. Non-invasive assessment of liver fibrosis in patients after the Fontan operation. Pediatr. Int., 2011, 53, 980-984.
[102]
Kothari, S.S. Non-cardiac issues in patients with heterotaxy syndromes. Ann. Pediatr. Cardiol., 2014, 7, 187-192.
[106]
Rajpal, S.; Alshawabkeh, L.; Opotowsky, A.R. Current role of blood and urine biomarkers in the clinical care of adults with congenital heart disease. Curr. Cardiol. Rep., 2017, 19(6), 50.
[107]
Fridman, M.D.; Mital, S. Perspective on precision medicine in paediatric heart failure. Clin. Sci. (Lond.), 2017, 131(6), 439-448.
[108]
Hansson, L.; Ohlund, I.; Lind, T.; Stecksen-Blicks, C.; Rydberg, A. Dietary intake in infants with complex congenital heart disease: A case-control study on macro- and micronutrient intake, meal frequency and growth. J. Hum. Nutr. Diet., 2014, 29(1), 67-74.
[109]
Zukunft, S.; Sorgenfrei, M.; Prehn, C.; Möller, G.; Adamski, J. Targeted Metabolomics of dried blood spot extracts. Chromatographia, 2013, 76, 1295-1305.
[110]
Peng, G.; Hakim, M.; Broza, Y.Y.; Billan, S.; Abdah-Bortnyak, R.; Kuten, A.; Tisch, U.; Haick, H. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer, 2010, 103(4), 542-551.
Download PDF Flyer